BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3329404)

  • 1. Biochemical and immunologic diagnosis of cancer. Colorectal cancer.
    von Kleist S
    Tumour Biol; 1987; 8(2-3):78-83. PubMed ID: 3329404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neopterin. A tumor marker in colorectal carcinoma?
    Putzki H; Aschern F; Henkel E; Heymann H
    Dis Colon Rectum; 1987 Nov; 30(11):879-83. PubMed ID: 3479311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
    von Kleist S
    Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
    Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic evaluation of tumor-associated glycoprotein-72 and carcinoembryonic antigen expression in colorectal cancer, Part I.
    Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Arcuri R; Abbolito MR; Greiner JW; Schlom J
    Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S16-23. PubMed ID: 8313787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of immunologic markers in the diagnosis and monitoring of large-intestinal neoplasms].
    Harłozińska-Szmyrka A
    Pol Arch Med Wewn; 1992; 88(2-3):181-9. PubMed ID: 1492024
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
    Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
    J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and immunologic diagnosis of cancer. Pancreatic and gastric cancer.
    Burtin P
    Tumour Biol; 1987; 8(2-3):84-5. PubMed ID: 2452469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
    Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
    Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
    [No Abstract]   [Full Text] [Related]  

  • 16. [Colonic cancer; problems of early diagnosis. 3. Neoplasm makers].
    Shimano T; Okuda H; Monden T; Morimoto H; Tamaki Y; Shimizu M; Inaji H; Saito M; Mori T
    Nihon Rinsho; 1988 Feb; 46(2):387-91. PubMed ID: 3164077
    [No Abstract]   [Full Text] [Related]  

  • 17. [Colorectal carcinoma. Diagnostic value of various biological markers in postoperative recurrences].
    Antón Aranda E; Martí Cabané J; Tiberio López G; Pérez Garciá C
    Rev Clin Esp; 1984 Jan; 172(2):69-73. PubMed ID: 6201959
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
    Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
    Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
    Bruhn HD; Broers H; Euler H; Everding A; Feller AC; Hedderich J; Jostarndt L; Jooss B; Zurborn KH; Löffler H
    Dtsch Med Wochenschr; 1986 Aug; 111(34):1267-72. PubMed ID: 3461933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.